Miguel Regueiro, MD
Gastroenterology · Pittsburgh, PANPI 1649245788
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $977,290 of the $1,511,279 with a category attached, or 64.7%. 22 manufacturers reported payments, led by AbbVie at 44.2% of the total. Among gastroenterology clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 864 payments — averaging $1749.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$669K
- Johnson & Johnson$217K
- E.r. Squibb & Sons, L.L.C.$125K
- Pfizer$95K
- Takeda Pharmaceuticals U.S.A., Inc.$93K
- Eli Lilly$88K
- plus $225K from 16 others
Across 45 payments — averaging $1380.67 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$62K
What the payments were for
- Consulting fees$474,28931%
- Speaking & faculty fees$977,29065%
- Travel & lodging$44,1013%
- Food & beverage$15,5451%
- Education$550%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 356 | $668,666 |
| Johnson & Johnson | 158 | $217,490 |
| E.r. Squibb & Sons, L.L.C. | 55 | $124,598 |
| Pfizer | 35 | $94,912 |
| Takeda Pharmaceuticals U.S.A., Inc. | 39 | $93,034 |
| Eli Lilly | 68 | $87,634 |
| Lilly USA, LLC | 26 | $50,601 |
| Janssen Scientific Affairs, LLC | 22 | $48,459 |
| Bristol Myers Squibb | 29 | $30,255 |
| Genentech, Inc. | 13 | $22,467 |
| Janssen Global Services, LLC | 17 | $18,769 |
| Gilead | 11 | $12,974 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 13 | $10,907 |
| Celltrion USA Inc. | 8 | $9,080 |
| Sebela Pharmaceuticals Inc. | 1 | $5,625 |
| Sanofi | 5 | $5,340 |
| Organon | 2 | $3,315 |
| Biocon Biologics Inc | 1 | $2,850 |
| Boehringer Ingelheim | 1 | $2,600 |
| UCB, Inc. | 1 | $1,320 |
| Boston Scientific | 2 | $260 |
| Madrigal Pharmaceuticals | 1 | $125 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,511,279 in reported general payments places this provider in the 95th percentile of 935 gastroenterology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other gastroenterology in Pittsburgh
- Sandra El-HachemPittsburgh$472K
- Elie AounPittsburgh$323K
- Gursimran KochharPittsburgh$217K
- Michael BabichPittsburgh$157K
- Heitham Abdul-BakiPittsburgh$92K
- Katie FarahPittsburgh$55K
- Adam PeytonAllentown$985K
- Shahin RahimianWaynesboro$592K
- Harshit KharaDanville$438K
- Kofi ClarkeHershey$426K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.